Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The Lancet. Infectious Diseases|February 6, 2021
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trialZhiwei Wu, Yaling Hu, Miao Xu, et al.
The Lancet. Infectious Diseases|December 10, 2021
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trialsGang Zeng, Qianhui Wu, Hongxing Pan, et al.
Vaccine|April 28, 2012
Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese childrenZhi-Lun Zhang, Xiang-Jun Zhu, Xu Wang, et al.
Nano-Micro Letters|March 13, 2026
Aggregation-Induced-Emission Luminogens Functionalized MXene Nanosheets for Stimuli-Responsive Hydrogel in Pyroptosis-Mediated Choroidal Melanoma TherapyYingni Xu, Fei Wang, Wenfang Liu, et al.
Vaccine|November 5, 2005
Preparation and characterization of SARS in-house reference antiserumJiansan Zhang, Yuxuan Liu, Liangxiang Hu, et al.
The Lancet. Infectious Diseases|November 20, 2020
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trialYanjun Zhang, Gang Zeng, Hongxing Pan, et al.
Nature Communications|June 4, 2013
Picornavirus uncoating intermediate captured in atomic detailJingshan Ren, Xiangxi Wang, Zhongyu Hu, et al.
Lancet (London, England)|September 19, 2006
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trialJiangtao Lin, Jiansan Zhang, Xiaoping Dong, et al.
Nature Structural & Molecular Biology|March 6, 2012
A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71Xiangxi Wang, Wei Peng, Jingshan Ren, et al.
Lancet (London, England)|April 11, 2008
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in ChinaHua Wang, Zijian Feng, Yuelong Shu, et al.
Pageof 7